Functional activity of peripheral blood monocytes in patients with opisthorchiasis coupled to liver fibrosis intensity
- Authors: Tsukanov V.V.1, Gorchilova E.G.2, Kolenchukova O.A.1, Gvozdev I.I.1, Savchenko A.A.1, Vasyutin A.V.1, Tonkikh J.L.1, Rzhavicheva O.S.2, Borisov A.G.1
-
Affiliations:
- Research Institute of Medical Problems of the North, Federal Research Center KSC SB RAS
- Private Healthcare Institution "Clinical hospital "RZD-Medicine" of Krasnoyarsk city
- Issue: Vol 11, No 2 (2021)
- Pages: 389-395
- Section: SHORT COMMUNICATIONS
- Submitted: 07.02.2020
- Accepted: 22.05.2020
- Published: 24.06.2020
- URL: https://iimmun.ru/iimm/article/view/1376
- DOI: https://doi.org/10.15789/2220-7619-FAO-1376
- ID: 1376
Cite item
Full Text
Abstract
The aim is to examine activity of peripheral blood monocytes from patients with opisthorchiasis coupled to intensity of liver fibrosis. Materials and Methods. A total of 74 patients with chronic opisthorchiasis (39 males and 35 females, average age 42.3 years) and 32 apparently healthy subjects (17 males and 15 females, average age 41.5 years) aged 24 to 60 years were enrolled. Opisthorchiasis was mainly diagnosed by parasitological assays to detect adult parasite eggs or bodies in duodenal contents and/or feces in all 74 patients. Liver fibrosis was assessed by elastometry according to the METAVIR scale. Functional activity of peripheral blood monocytes was performed in all patients with opisthorchiasis and healthy individuals from the control group by chemiluminescent analysis to measure intensity of reactive oxygen species production in lucigenin- and luminol-dependent spontaneous and zymosan-induced reactions. Results. Liver fibrosis F2 and F3—F4 stage according to METAVIR scale was found in 20.3% and 17.6% of patients with opisthorchiasis, respectively. While analyzing total pool of reactive oxygen species in the luminol-dependent process in patients with opisthorchiasis, a significantly decreased monocyte functional activity was observed as compared to healthy subjects that was evidenced by significantly decreased maximum intensity of produced reactive oxygen species as well as area under the chemiluminescence curve both in spontaneous and zymosan-induced reaction. Such parameters in liver fibrosis F3—F4 compared to F0—F1 in zymosan-induced response were lowered. Monocyte functional activity in spontaneous luminol-dependent reaction did not differ significantly depending on liver fibrosis intensity in patients with opisthorchiasis. The phagocytosis activation index in patients with opisthorchiasis with liver fibrosis F3—F4 compared to F0—F1 and F2 stage was lower. Similar changes were observed in the lucigenin-dependent reaction. Conclusion. The data obtained undoubtedly provide promising evidence to interpret the mechanisms behind liver fibrosis in patients with opisthorchiasis and create new opportunities for development of diagnostic and therapeutic technologies.
About the authors
V. V. Tsukanov
Research Institute of Medical Problems of the North, Federal Research Center KSC SB RAS
Author for correspondence.
Email: gastro@impn.ru
ORCID iD: 0000-0002-9980-2294
Vladislav V. Tsukanov - PhD, MD (Medicine), Professor, Head of the Clinical Department of the Digestive System Pathology of Adults and Children, Research Institute of Medical Problems of the North, Federal Research Center KSC SB RAS.
660022, Krasnoyarsk, Partizan Zheleznyak str., 3-G.
Phone: +7 (391) 256-81-71; Fax: +7 (391) 228-06-83
SPIN: 2529-9513
РоссияE. G. Gorchilova
Private Healthcare Institution "Clinical hospital "RZD-Medicine" of Krasnoyarsk city
Email: yourself.15@mail.ru
Gastroenterologist, Gastroenterological Department, Private Healthcare Institution Clinical hospital “RZD-Medicine” of Krasnoyarsk city.
Krasnoyarsk.
РоссияO. A. Kolenchukova
Research Institute of Medical Problems of the North, Federal Research Center KSC SB RAS
Email: kalina-chyikova@mail.ru
ORCID iD: 0000-0001-9552-447X
PhD, MD (Biology), Leading Researcher, Laboratory of Molecular and Cellular Physiology and Pathology, Research Institute of Medical Problems of the North, Federal Research Center KSC SB RAS.
Krasnoyarsk.
SPIN: 8008-5580
РоссияI. I. Gvozdev
Research Institute of Medical Problems of the North, Federal Research Center KSC SB RAS
Email: leshman-mult@mail.ru
Junior Researcher, Laboratory of Molecular and Cellular Physiology and Pathology, Research Institute of Medical Problems of the North, Federal Research Center KSC SB RAS.
Krasnoyarsk.
SPIN: 6203-4651
РоссияA. A. Savchenko
Research Institute of Medical Problems of the North, Federal Research Center KSC SB RAS
Email: aasavchenko@yandex.ru
PhD, MD (Medicine), Professor, Head of the Laboratory of Molecular and Cellular Physiology and Pathology, Research Institute of Medical Problems of the North, Federal Research Center KSC SB RAS.
Krasnoyarsk.
SPIN: 3132-8260
РоссияA. V. Vasyutin
Research Institute of Medical Problems of the North, Federal Research Center KSC SB RAS
Email: alexander@kraslan.ru
ORCID iD: 0000-0002-6481-3196
PhD (Medicine), Senior Researcher, Clinical Department of the Digestive System Pathology of Adults and Children, Research Institute of Medical Problems of the North, Federal Research Center KSC SB RAS.
Krasnoyarsk.
SPIN: 4075-4538
РоссияJ. L. Tonkikh
Research Institute of Medical Problems of the North, Federal Research Center KSC SB RAS
Email: tjulia@bk.ru
ORCID iD: 0000-0001-7518-1895
PhD (Medicine), Leading Researcher, Clinical Department of the Digestive System Pathology of Adults and Children, Research Institute of Medical Problems of the North, Federal Research Center KSC SB RAS.
Krasnoyarsk.
SPIN: 3292-9128
РоссияO. S. Rzhavicheva
Private Healthcare Institution "Clinical hospital "RZD-Medicine" of Krasnoyarsk city
Email: ros315@yandex.ru
PhD (Medicine), Head of the Gastroenterological Department, Private Healthcare Institution Clinical hospital “RZD-Medicine” of Krasnoyarsk city.
Krasnoyarsk.
РоссияA. G. Borisov
Research Institute of Medical Problems of the North, Federal Research Center KSC SB RAS
Email: 2410454@mail.ru
ORCID iD: 0000-0002-9026-2615
PhD (Medicine), Leading Researcher, Laboratory of Molecular and Cellular Physiology and Pathology, Research Institute of Medical Problems of the North, Federal Research Center KSC SB RAS.
Krasnoyarsk.
SPIN: 9570-2254
РоссияReferences
- Цуканов В., Горчилова Е., Васютин А., Тонких Ю., Ржавичева О. Современные принципы ведения больных с описторхозом // Врач. 2019. Т. 30, № 12. С. 25-28. doi: 10.29296/25877305-2019-12-07
- Цуканов В.В., Тонких Ю.Л., Гилюк А.В., Васютин А.В., Коленчукова О.А., Ржавичева О.С., Борисов А.Г., Савченко А.А., Масленникова Н.А. Диагностика, клиника и лечение описторхоза // Доктор.Ру. 2019. № 8 (163). С. 49-53. doi: 10.31550/1727-2378-2019-163-8-49-53
- Bernal W., Wendon J. Acute liver failure. N. Engl. J. Med., 2013, vol. 369, no. 26, pp. 2525—2534. doi: 10.1056/NEJMra1208937
- Bouvard V., Baan R., Straif K., Grosse Y., Secretan B., El Ghissassi F., Benbrahim-Tallaa L., Guha N., Freeman C., Galichet L., Cogliano V. A review of human carcinogens — Part B: biological agents. The Lancet. Oncology, 2009, vol. 10, no. 4, pp. 321—322. doi: 10.1016/s1470-2045(09)70096-8
- Brempelis K.J., Crispe I.N. Infiltrating monocytes in liver injury and repair. Clin. Transl. Immunology, 2016, vol. 5, no. 11: e113. doi: 10.1038/cti.2016.62
- Heymann F., Tacke F. Immunology in the liver — from homeostasis to disease. Nat. Rev. Gastroenterol. Hepatol., 2016, vol. 13, no. 2, pp. 88—110. doi: 10.1038/nrgastro.2015.200
- Krenkel O., Tacke F. Liver macrophages in tissue homeostasis and disease. Nat. Rev. Immunol., 2017, vol. 17, no. 5, pp. 306—321. doi: 10.1038/nri.2017.11
- Pellicoro A., Aucott R.L., Ramachandran P., Robson A.J., Fallowfield J.A., Snowdon V.K., Hartland S.N., Vernon M., Duffield J.S., Benyon R.C., Forbes S.J., Iredale J.P. Elastin accumulation is regulated at the level of degradation by macrophage metalloelastase (MMP-12) during experimental liver fibrosis. Hepatology, 2012, vol. 55, no. 6, pp. 1965—1975. doi: 10.1002/hep.25567
- Poynard T., Bedossa P., Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet, 1997, vol. 349, no. 9055,pp. 825-832. doi: 10.1016/s0140-6736(96)07642-8
- Pradere J.P., Kluwe J., De Minicis S., Jiao J.J., Gwak G.Y., Dapito D.H., Jang M.K., Guenther N.D., Mederacke I., Friedman R., Dragomir A.C., Aloman C., Schwabe R.F. Hepatic macrophages but not dendritic cells contribute to liver fibrosis by promoting the survival of activated hepatic stellate cells in mice. Hepatology, 2013, vol. 58, no. 4, pp. 1461-1473. doi: 10. 1002/hep.26429
- Prueksapanich P., Piyachaturawat P., Aumpansub P., Ridtitid W., Chaiteerakij R., Rerknimitr R. Liver fluke-associated biliary tract cancer. Gut Liver, 2018, vol. 12, no. 3, pp. 236-245. doi: 10.5009/gnl17102
- Schuppan D., Kim Y.O. Evolving therapies for liver fibrosis. J. Clin. Invest., 2013, vol. 123, no. 5, pp. 1887-1901. doi: 10.1172/JCI66028
- Sripa B., Kaewkes S., Intapan P.M., Maleewong W., Brindley P.J. Food-borne trematodiases in Southeast Asia epidemiology, pathology, clinical manifestation and control. Adv. Parasitol., 2010, vol. 72, pp. 305-350. doi: 10.1016/S0065-308X(10)72011-X
- Strnad P., Tacke F., Koch A., Trautwein C. Liver — guardian, modifier and target of sepsis. Nat. Rev. Gastroenterol. Hepatol., 2017, vol. 14, no. 1, pp. 55- 66. doi: 10.1038/nrgastro.2016.168
- Tacke F., Zimmermann H.W. Macrophage heterogeneity in liver injury and fibrosis. J. Hepatol., 2014, vol. 60, no. 5, pp. 10901096. doi: 10.1016/j.jhep.2013.12.025
- Triantafyllou E., Woollard K.J., McPhail M.J.W., Antoniades C.G., Possamai L.A. The role of monocytes and macrophages in acute and acute-on-chronic liver failure. Front. Immunol., 2018, vol. 9: 2948. doi: 10.3389/fimmu.2018.02948